PureTech Health plc (LON:PRTC – Get Free Report) crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 128.35 ($1.74) and traded as high as GBX 140.80 ($1.90). PureTech Health shares last traded at GBX 140.80 ($1.90), with a volume of 208,416 shares traded.
PureTech Health Stock Up 0.9%
The company has a fifty day moving average price of GBX 128.35 and a 200 day moving average price of GBX 141.33. The company has a market cap of £426.54 million, a PE ratio of -5.83 and a beta of 1.02. The company has a debt-to-equity ratio of 45.82, a current ratio of 3.68 and a quick ratio of 2.51.
PureTech Health Company Profile
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
Featured Stories
- Five stocks we like better than PureTech Health
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Among the Market’s Most Shorted: 2 Firms With +40% Short Interest
- How to Invest in Biotech Stocks
- Ollie’s Q1 Earnings: The Good, the Bad, and What’s Next
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Rocket Lab Expands Into Payloads: Should You Be Paying Attention?
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
